Skip to content

Intrapartum electrophysiological monitoring: pilot study

Implementation of intrapartum non-invasive electrophysiological monitoring: a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25234
Enrollment
50
Registered
2019-09-13
Start date
2021-03-10
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant women during delivery

Interventions

None

Sponsors

Máxima MC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Pregnant women with a gestational age between 36 and 42 weeks - Admission to the labor ward because of labor and indication for fetal monitoring during labor - Singleton fetus in cephalic presentation - Oral and written informed consent is obtained

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Women under the age of 18 years - Language barrier (Patient information folder is available in English and Dutch) - Women with a multiple pregnancy - Fetal cardiac arrhythmias (detected and confirmed during pregnancy by ultrasound) - Contraindications to abdominal patch placement (dermatological disease of the abdomen precluding preparation of the abdomen with abrasive paper) - Women in labor taking a bath (because the Bluetooth signal is disturbed and monitoring is impossible). It is possible to take a shower. - Women connected to external or implanted electrical stimulators, such as Transcutaneous Electro Neuro Stimulation (TENS) and pacemaker (because of disturbance of the electrophysiological signal we want to measure, not because of danger for mother or child). - Contraindications for monitoring using a FSE (coagulation disorders and maternal infections like HIV or hepatitis)

Design outcomes

Primary

MeasureTime frame
Percentage of switch to fetal scalp electrode and external tocodynamometry in the primary and secondary stage of labor and the reason of switch. Amount of signal loss during primary and secondary stage of labor

Secondary

MeasureTime frame
Percentage and result of fetal blood sampling in the primary and secondary stage of labor. EHG pattern and the possible association with amount of blood loss within the first one and a half hour postpartum. To assess EHG patern within the first one and a half hour postpartum in relation to medication use and placental expulsion. To assess EHG patterns before and after labor analgesia. Frequency of replacement of abdominal patch during labor. Other outcomes: This sample of patients will be a part of a greater study population to evaluate the effects of clinical implementation of NI-fECG and EHG monitoring on neonatal and maternal outcome. Retrospectively we will correlate fECG waveform details to clinical parameters and outcomes.

Contacts

Public ContactMarion Frenken

Máxima Medisch Centrum, Veldhoven

marion.frenken@mmc.nl040-8888380

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)